Number of pages: 100 | Report Format: PDF | Published date: January 19, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
Report Attribute |
Details |
Market Size Value in 2021 |
US$ 1.7 billion |
Revenue Forecast in 2030 |
US$ 2.76 billion |
CAGR |
5.4% |
Base Year for Estimation |
2021 |
Forecast period |
2022-2030 |
Historical Year |
2020 |
Segments Covered |
Type, Treatment type, End-user, and Region |
Regional Scope |
North America, Europe, Asia Pacific, and the Rest of the World (RoW) |
According to the deep-dive market assessment study by Growth Plus Reports, the global kidney stone management market was valued at US$ 1.70 billion in 2021 and is expected to register a revenue CAGR of 5.4% to reach US$ 2.76 billion by 2030.
Kidney Stone Management Market Fundamentals
A kidney stone is a hard stone formed in the kidney from minerals and salts, blocking the areas from the urinary tract to the bladder. In some cases, this medical condition can cause severe kidney damage. Thus, kidney stones are removed using different medical procedures/techniques to avoid such scenarios. Increasing obesity, poor diet, lack of water intake, and unhealthy lifestyle are a few risk factors for kidney stones.
[283402]
Kidney Stone Management Market Dynamics
The kidney stone management market is growing steadily and is expected to register continuous revenue growth during the forecast period. This can be attributed to rising prevalence of kidney stones, increasing technological innovations, and the growing adoption of a sedentary lifestyle. Furthermore, growing collaborations and acquisitions and rising adoption of minimally invasive surgeries/procedures contribute to market revenue growth. Additionally, the increasing geriatric population further boosts revenue growth in the market.
However, side effects associated with the lithotripsy procedure are likely to restrain the revenue growth of the market to some extent.
Kidney Stone Management Market Ecosystem
The global kidney stone management market is analyzed from four perspectives: type, treatment type, end-user, and region.
Kidney Stone Management Market by Type
[1983038]
Based on the type, the global kidney stone management market is segmented into calcium oxide, calcium oxalate, cysteine, and others (uric acid stone and struvite acid stone).
The calcium oxalate segment dominates the market with the largest revenue share. Calcium oxalate is the most common type of kidney stone among patients. Lifestyle-associated factors, such as high intake of protein, dehydration, and obesity, augment the risk for the formation of calcium oxalate stones.
Kidney Stone Management Market by Treatment Type
Based on the treatment type, the global stone kidney stone management market is segmented into lithotripsy, percutaneous nephrolithotomy (PCNL), and ureteroscopy.
The ureteroscopy segment accounts for the largest revenue share of the market. This is attributed to various benefits of ureteroscopy, such as being a minimally invasive technique, improved outcomes, and helping in avoiding the reoccurrence of kidney stones. Furthermore, a fast recovery rate and relatively minor medical procedures also contribute to the revenue growth of the ureteroscopy segment.
Kidney Stone Management Market by End-User
Based on the end-user, the kidney stone management market is segmented into hospitals, ambulatory surgical centers, and specialty clinics.
The hospitals segment leads the market with the largest revenue share. This can be attributed to the high patient footfall and availability of advanced technologies/treatment methods in hospitals. Furthermore, favorable reimbursement policies also facilitate greater patient footfall in hospitals.
The specialty clinics segment is expected to register high revenue growth during the forecast period. This can be attributed to the involvement of specialized surgeons/medical professionals focusing on only renal diseases and convenient and faster treatments available at specialty clinics.
Kidney Stone Management Market by Region
Based on the region, the global kidney stone management market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW).
North America dominates the kidney stone management market with the largest revenue share. The high revenue growth in this region can be attributed to various factors, such as beneficial reimbursement policies, high implementation rate of innovative and advanced technologies, and rising launch of novel technologies. Additionally, a large patient pool and high awareness about kidney stone problems among the population contribute to the market revenue growth in this region.
Europe accounts for the second-largest revenue share of the market due to the presence of well-developed healthcare infrastructure, increase in healthcare expenditure, and rise in utilization of innovative treatment techniques.
Kidney Stone Management Market Competitive Landscape
The prominent players operating in the global kidney stone management market are:
Kidney Stone Management Market Strategic Developments
Asia Pacific is the fastest-growing region for the kidney stone management market.
The kidney stone management market is estimated to be valued at US$ 2.76 billion in 2030.
The global kidney stone management market is expected to register a revenue CAGR of 5.4% during the forecast period.
Boston Scientific Corporation, EDAP TMS SA, Cook Group Incorporated, Richard Wolf GmbH, DirexGroup, and Siemens Healthcare GmbH are among the key players operating in the global kidney stone management market.
*Insights on financial performance are subject to the availability of information in the public domain